With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

The topic of prostate cancer made the news earlier this year when former US president Joe Biden revealed that he had been ...

A new article urges Canada to rethink how it uses the prostate-specific antigen test, which comes with its own risks ...

Oregon surgeons began using a non-invasive robotic device to destroy prostate cancer, which is the second leading cause of ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

I must begin this story by emphasising the importance of periodic medical examinations to ensure that any illness is detected ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National ...

In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

During Monday's episode of On Air with Ryan Seacrest, Ryan Seacrest opened up about his father, Gary Seacrest's, battle with ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...